Results 61 to 70 of about 57,525 (156)

Reagent Effects on the Activated Partial Thromboplastin Time Clot Waveform Analysis: A Multi-Centre Study. [PDF]

Diagnostics (Basel), 2023
Wong WH, Tan CW, Abdul Khalid NB, Dalimoenthe NZ, Yip C, Tantanate C, Lim RD, Kim JH, Ng HJ.   +8 more
europepmc   +1 more source

Identifying the silent deficiency: Severe Factor XI deficiency in an asymptomatic patient with isolated prolonged activated partial thromboplastin time-A case report. [PDF]

SAGE Open Med Case Rep
Alshurafa A, Draidi M, Ibrahim F, Mohamed SF, Yassin MA.   +4 more
europepmc   +1 more source

International normalized ratio and activated partial thromboplastin time testing. [PDF]

CMAJ, 2022
Chornenki NLJ, Fralick M, Sholzberg M.
europepmc   +1 more source

Diagnostic Performance of Prothrombin Time and Activated Partial Thromboplastin Time in Children: A Service Evaluation. [PDF]

Int J Lab Hematol
Gurumurthy G, Lemma M, Reynolds L, Grainger J, Thachil J.   +4 more
europepmc   +1 more source

Comparative analysis on characteristics of two activated partial thromboplastin time reagents. [PDF]

J Clin Lab Anal, 2022
Yasui Y, Ishii T, Tatebe J, Morita T.
europepmc   +1 more source

Laboratory Identification of Lupus Anticoagulant (LA) Using Different Activated Partial Thromboplastin Time (APTT) Assays. [PDF]

Int J Lab Hematol
Barion BG, Stefanello B, de Paula MLSA, Saraiva TS, Villaça PR, Rocha V, Orsi FA, da Rocha TRF.   +7 more
europepmc   +1 more source

Activated Partial Thromboplastin Time and Mortality in Coronary Artery Bypass Grafting Patients. [PDF]

Dis Markers, 2022
Zhang H, Tian W, Qi G, Sun L, Wei X.
europepmc   +1 more source

Activated partial thromboplastin time prolongation without hemorrhagic dienhesis: a study of a chinese family coexisting with hereditary KNG1 p.Arg240 mutation and --SEA/αα genotype thalassemia. [PDF]

Ann Hematol
Bai Z, Hu J, Jin Y, Li X, Sun J, Zhang F, Wu D, Zhao F, Ji P.   +8 more
europepmc   +1 more source

Variation in coagulation factor activity levels cause discrepancies between activated partial thromboplastin time and anti-Xa activity for heparin monitoring: a retrospective observational study. [PDF]

J Intensive Care, 2023
Saito T, Hayakawa M, Kumano O, Honma Y, Murashita M, Kato J, Fukui S, Takahashi M, Takahashi Y, Tsuchida T, Mizugaki A, Takauji S, Hayamizu M, Yoshida T, Katabami K, Wada T, Maekawa K.   +16 more
europepmc   +1 more source

Survey of clot waveform analysis of normal activated partial thromboplastin time in patients with cirrhosis and sepsis at Le Van Thinh hospital. [PDF]

PLoS One
Phuong Linh TQ, Nhan NT, Thuan LM, Phuong LT.   +3 more
europepmc   +1 more source